Sort   by:  
 Page size 
UnknownBurosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level.
Not available
S-EPMC10583998 | biostudies-literature
UnknownBurosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period.
Not available
S-EPMC11059996 | biostudies-literature
UnknownBurosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.
Not available
S-EPMC7179969 | biostudies-literature
UnknownPatient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia.
Not available
S-EPMC8064984 | biostudies-literature
UnknownFluid challenges in intensive care: the FENICE study: A global inception cohort study.
Not available
S-EPMC4550653 | biostudies-literature
Sort   by:  
 Page size